Veru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin Treatment of Hospitalized COVID-19 Adult Patients at High Risk for ARDS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: VERU) | Delayed: 2.27 -0.01 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.28 | 52 Week High | $ | |||
| Open | $2.27 | 52 Week Low | $ | |||
| Day High | $2.30 | P/E | N/A | |||
| Day Low | $2.26 | EPS | $ | |||
| Volume | 25,323 | |||||
